Cypress Capital Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.8M Sell
80,951
-3,004
-4% -$700K 2.23% 10
2025
Q4
$17.4M Buy
83,955
+6,265
+8% +$1.24M 1.95% 13
2025
Q3
$14.4M Buy
77,690
+3,801
+5% +$651K 1.72% 15
2025
Q2
$11.3M Buy
73,889
+1,366
+2% +$210K 1.4% 19
2025
Q1
$12M Sell
72,523
-1,744
-2% -$273K 1.58% 14
2024
Q4
$10.7M Sell
74,267
-4,162
-5% -$645K 1.32% 19
2024
Q3
$12.7M Sell
78,429
-1,834
-2% -$292K 1.43% 13
2024
Q2
$11.7M Sell
80,263
-1,053
-1% -$157K 1.41% 13
2024
Q1
$12.9M Buy
81,316
+1,283
+2% +$204K 1.54% 10
2023
Q4
$12.5M Sell
80,033
-67
-0.1% -$10.3K 1.63% 9
2023
Q3
$12.5M Sell
80,100
-2,047
-2% -$338K 1.8% 8
2023
Q2
$13.6M Sell
82,147
-6,553
-7% -$1.06M 1.97% 7
2023
Q1
$13.7M Sell
88,700
-2,916
-3% -$471K 2.11% 7
2022
Q4
$16.2M Sell
91,616
-933
-1% -$161K 2.44% 7
2022
Q3
$15.1M Sell
92,549
-4,671
-5% -$790K 2.52% 6
2022
Q2
$17.3M Sell
97,220
-287
-0.3% -$51.1K 2.63% 6
2022
Q1
$17.3M Buy
97,507
+10,426
+12% +$1.77M 2.13% 7
2021
Q4
$14.9M Sell
87,081
-1,850
-2% -$303K 1.87% 9
2021
Q3
$14.4M Sell
88,931
-1,792
-2% -$306K 1.95% 10
2021
Q2
$14.9M Buy
90,723
+744
+0.8% +$123K 2.03% 8
2021
Q1
$14.8M Buy
89,979
+1,852
+2% +$300K 2.1% 7
2020
Q4
$13.9M Sell
88,127
-2,030
-2% -$300K 2.09% 8
2020
Q3
$13.4M Buy
90,157
+8,297
+10% +$1.23M 2.24% 6
2020
Q2
$11.5M Sell
81,860
-28
-0% -$4.08K 2.11% 8
2020
Q1
$10.7M Sell
81,888
-596
-0.7% -$84.6K 2.48% 6
2019
Q4
$12M Sell
82,484
-2,447
-3% -$332K 2.14% 8
2019
Q3
$11M Sell
84,931
-11,593
-12% -$1.53M 2.12% 6
2019
Q2
$13.4M Buy
96,524
+5,147
+6% +$712K 2.65% 3
2019
Q1
$12.8M Buy
91,377
+839
+0.9% +$112K 2.61% 3
2018
Q4
$11.7M Buy
90,538
+4,381
+5% +$611K 2.68% 5
2018
Q3
$11.9M Buy
86,157
+333
+0.4% +$44.3K 2.26% 5
2018
Q2
$10.4M Sell
85,824
-7,570
-8% -$944K 2.15% 5
2018
Q1
$12M Sell
93,394
-1,214
-1% -$164K 2.51% 4
2017
Q4
$13.2M Sell
94,608
-4,506
-5% -$628K 2.75% 4
2017
Q3
$12.9M Buy
99,114
+1,868
+2% +$248K 2.75% 4
2017
Q2
$12.9M Buy
97,246
+5,140
+6% +$656K 2.85% 3
2017
Q1
$11.5M Sell
92,106
-530
-0.6% -$63.3K 2.68% 3
2016
Q4
$10.7M Sell
92,636
-2,029
-2% -$234K 2.53% 4
2016
Q3
$11.2M Sell
94,665
-1,174
-1% -$142K 2.67% 4
2016
Q2
$11.6M Sell
95,839
-512
-0.5% -$58.2K 2.72% 4
2016
Q1
$10.4M Sell
96,351
-2,701
-3% -$280K 2.55% 4
2015
Q4
$10.2M Sell
99,052
-1,425
-1% -$143K 2.45% 5
2015
Q3
$9.38M Buy
100,477
+990
+1% +$95.8K 2.31% 5
2015
Q2
$9.7M Buy
99,487
+570
+0.6% +$57.1K 2.23% 6
2015
Q1
$9.95M Buy
98,917
+2,236
+2% +$227K 2.27% 5
2014
Q4
$10.1M Buy
96,681
+854
+0.9% +$90K 2.34% 6
2014
Q3
$10.2M Sell
95,827
-631
-0.7% -$65.4K 2.43% 3
2014
Q2
$10.1M Buy
96,458
+1,733
+2% +$175K 2.37% 3
2014
Q1
$9.3M Sell
94,725
-111
-0.1% -$10.3K 2.28% 4
2013
Q4
$8.69M Sell
94,836
-73
-0.1% -$6.73K 2.13% 5
2013
Q3
$8.23M Sell
94,909
-13,052
-12% -$1.17M 2.03% 7
2013
Q2
$9.27M Buy
+107,961
New +$9.16M 1.94% 8

Other funds holding JNJ

Cypress Capital Group's JNJ Position: Q1 2026 in Review

Cypress Capital Group reduced its Johnson & Johnson (JNJ) stake by 3.6% in Q1 2026, selling an estimated $700K and leaving 80,951 shares worth $19.8M. The position accounts for 2.23% of the portfolio, ranked #10.

Cypress Capital Group first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Cypress Capital Group held 80,951 shares of Johnson & Johnson worth $19.8M as of Q1 2026.
  • Cypress Capital Group sold 3,004 Johnson & Johnson shares in Q1 2026, an estimated $700K.
  • Johnson & Johnson made up 2.23% of Cypress Capital Group's portfolio in Q1 2026, its #10 holding.
  • Cypress Capital Group first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Cypress Capital Group's 13F filing for Q1 2026, filed 15 May 2026.